1,184 results on '"Leufkens, H.G.M."'
Search Results
2. The role of science, practice and education in building capacity for pharmacy and pharmaceutical sciences
3. A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making
4. Role of Small and Medium-Sized Enterprises and Partnering in Drug Innovation
5. The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink
6. Selection of oncology medicines in low- and middle-income countries
7. Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement
8. The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non‐valvular atrial fibrillation
9. Access to sexual and reproductive health medicines and supplies in Sub-Saharan Africa
10. Post-marketing safety learning for biologicals: regulatory and clinical insights
11. Development, market authorization and market access of gene and cell-based therapies
12. A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature
13. The Application and Implications of Novel Deterministic Sensitivity Analysis Methods
14. Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review
15. A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature
16. Health Technology Assessment Throughout the Drug Lifecycle
17. A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature
18. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
19. PDG61 Incorporating Uncertainty in Clinical Benefit in Health Technology Assessments: A Review and Classification of Agency Approaches
20. A simple clinical score for estimating the long-term risk of fracture in post-menopausal women
21. Statin treatment and reduced risk of pneumonia in patients with diabetes
22. A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids
23. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
24. Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia
25. Presenting the bill: a research about the costs and barriers in drug rediscovery
26. Predicting mortality in patients with heart failure: a pragmatic approach. (Cardiovascular Medicine)
27. The use of inhaled corticosteroids in the United Kingdom and the Netherlands
28. Challenges in Advanced Therapy Medicinal Products Development: A survey amongst companies in Europe
29. Response to proposal for a novel cancer drug pricing model
30. Response to proposal for a novel cancer drug pricing model
31. Challenges in Advanced Therapy Medicinal Products Development: A survey amongst companies in Europe
32. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
33. Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons
34. Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study
35. Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study
36. Risk of infections in patients with gout: a population-based cohort study
37. Are age-appropriate antibiotic formulations missing from the WHO list of essential medicines for children? A comparison study
38. Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons
39. 'Threshold-crossing': A Useful Way to Establish the Counterfactual in Clinical Trials?
40. Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis
41. Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project
42. Non-publication is common amomg phase 1, single-center, not prospectively registered, or early terminated clinical drug trials: results of a nationwide inception cohort study in the Netherlands
43. Asthma therapy during the first 8 years of life: a PIAMA cohort study
44. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands
45. Antibiotic prescribing for children in primary care and adherence to treatment guidelines
46. Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia
47. Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis
48. 'Threshold-crossing': A Useful Way to Establish the Counterfactual in Clinical Trials?
49. Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia
50. Antibiotic prescribing for children in primary care and adherence to treatment guidelines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.